IDH1 and astrocytoma (excluding glioblastoma): To assess CIN in tumors of GBM-TS, GBM-LTS and IDH-MUT grade 4 astrocytomas within a larger dataset using an orthogonal method, we decided to interrogate the TCGA-GBM cohort.